logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Fei Zhou

Tongji University School of Medicine
H指数:38
被引数:5,677

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer

EGFR突变型早期可切除非小细胞肺癌中分子残留病灶检测的临床应用

Nature Communications
IF15.7
2026-08-100
OA
Fei Zhou; Chunxia Su; Wenhua Liang; Li-Di Xu; Wei Tao; Juanjuan Qian; Shidong Xu; Dan Liu; Rui Fan; Yaxi Zhang; Yiqian Liu; Lin Wu; Xiangning Fu; Xiaodong Zhang; Ning Shen; Di Ge; Qun Chen; Weimin Mao; Lin Xu; Chun Chen; Bing Hu; Guoguang Shao; Jian Hu; Jian Zhao; Xiaoqing Liu; Zhidong Liu; Zheng Wang; Zemin Xiao; Taiqian Gong; Wen Lin; Xingya Li; Feng Ye; Yang Liu; Haitao Ma; Yunchao Huang; Jianying Zhou; Zhonglin Wang; Junke Fu; Lieming Ding; Li Mao; Weizhi Chen; Jianxing He; Caicun Zhou
Anlotinib added to third generation EGFR tyrosine kinase inhibitor therapy for advanced NSCLC patients with oligo-progression: a retrospective study (ALTER-L058)

安罗替尼联合第三代EGFR酪氨酸激酶抑制剂治疗寡进展的晚期NSCLC患者的回顾性研究（ALTER-L058）

Frontiers in Pharmacology
IF4.8
2025-11-070
OAAI
Fei Zhou†; Minglei Zhuo†; Hongmin Wang†; Nong Yang; Jisheng Li; Shi Jin; Zhengxiang Han; Guilin Zeng; Jun Liu; Yang Song; Kangwu Wang; Dabing Huang; Ling Li; Jian Chen; Jinghui Bai; Fengming Ran; Caicun Zhou
Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature review

tislelizumab联合化疗治疗转移性三阴性乳腺癌的最佳反应: 病例报告和文献复习

FRONTIERS IN ONCOLOGY
IF3.3
2024-03-280
OAAI
Ma, Yuxin; Shi, Xinhong; Zhao, Kun; Hu, Shuyi; Shi, Yue; Jiang, Yingying; Liu, Yiling; Lu, Lin; Chang, Yuting; Zhou, Fei; Dai, Yingying; Wu, Zipeng; Li, Shiyi; Qian, Zhiying; Xu, Xia; Li, Chenchen; Shen, Bo; Zhou, Guoren; Chen, Cheng; Wang, Xiaohua; Feng, Jifeng
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapy

EGFR突变的晚期非小细胞肺癌患者在egfr-tki治疗失败后化疗-抗血管生成与化疗-免疫疗法联合治疗的真实世界结果

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2021-09-0114
OAAI
Yu, Xin; Li, Jiaqi; Ye, Lingyun; Zhao, Jing; Xie, Mengqing; Zhou, Juan; Shen, Yinchen; Zhou, Fei; Wu, Yan; Han, Chaonan; Qian, Jialin; Chu, Tianqing; Su, Chunxia

研究方向

暂未获取到该数据
C
Chunxia Su
H 指数:45论文数:272被引数:7,300
任胜祥 封面图
任胜祥
H 指数:59论文数:390被引数:1.6万
G
Guanghui Gao
H 指数:37论文数:149被引数:4,431
李雪飞 封面图
李雪飞
H 指数:49论文数:253被引数:8,502
C
Chao Zhao
H 指数:38论文数:187被引数:4,994
C
Caicun Zhou
H 指数:29论文数:58被引数:2,866
T
Tao Jiang
H 指数:49论文数:363被引数:8,693
F
Fengying Wu
H 指数:29论文数:171被引数:4,187
M
Meng Qiao
H 指数:38论文数:156被引数:6,217
C
Caicun Zhou
H 指数:49论文数:390被引数:1.1万